Pineapple Express Cannabis (PNXP) EPS (Weighted Average and Diluted) (2018 - 2024)
Pineapple Express Cannabis' (PNXP) quarterly EPS (Weighted Average and Diluted) came in at -$0.0 in Q4 2024, up 39.48% year-on-year from -$0.0 in Q4 2023, and down 129.08% quarter-over-quarter from $0.0 in Q3 2024.
Pineapple Express Cannabis (PNXP) EPS (Weighted Average and Diluted) (2018 - 2024) Analysis & Trends
Pineapple Express Cannabis has disclosed EPS (Weighted Average and Diluted) across 7 years of filings, most recently posting -$0.0 for Q4 2024.
- EPS (Weighted Average and Diluted) for Q4 2024 came in at -$0.0, up 39.48% year-over-year; the trailing twelve-month figure through Oct 2024 was $0.01 (down 66.67% YoY), and the FY2024 annual result was $0.01, up 527.62% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.0 for Q4 2024 at Pineapple Express Cannabis, down from $0.0 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.03 in Q3 2023 to a low of -$0.0 in Q2 2020.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.0 (2023), against an average of $0.0.
- Across the five-year window, EPS (Weighted Average and Diluted) tumbled 466.99% in 2022 and jumped 8337.98% in 2023, its largest moves.
- Pineapple Express Cannabis' EPS (Weighted Average and Diluted) stood at $0.0 in 2020, then plunged by 84.77% to $0.0 in 2021, then sank by 466.99% to -$0.0 in 2022, then surged by 89.7% to -$0.0 in 2023, then jumped by 39.48% to -$0.0 in 2024.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q4 2024), $0.0 (Q3 2024), and -$0.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Pineapple Express Cannabis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2024 | 0.00 |
| Jul 31, 2024 | 0.00 |
| Apr 30, 2024 | 0.00 |
| Jan 31, 2024 | 0.01 |
| Oct 31, 2023 | 0.00 |
| Jul 31, 2023 | 0.03 |
| Apr 30, 2023 | 0.01 |
| Jan 31, 2023 | 0.00 |
| Oct 31, 2022 | 0.00 |
| Jul 31, 2022 | 0.00 |
| Apr 30, 2022 | 0.00 |
| Oct 31, 2021 | 0.00 |
| Jul 31, 2021 | 0.01 |
| Apr 30, 2021 | 0.00 |
| Jan 31, 2021 | 0.00 |
| Oct 31, 2020 | 0.00 |
| Jul 31, 2020 | 0.00 |
| Apr 30, 2020 | 0.00 |
| Jan 31, 2020 | 0.00 |
| Oct 31, 2019 | 0.00 |